TRCT
XAGE

Tower Research Capital (TRC)’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Tower Research Capital (TRC)’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,631
Closed -$4.11K – 5753
2025
Q2 		$4.11K Buy
+1,631
New +$5.96K ﹤0.01% 4377
2024
Q4 		– Sell
-127
Closed -$1.54K – 6091
2024
Q3 		$1.54K Buy
127
+55
+76% +$1.5K ﹤0.01% 5142
2024
Q2 		$2.87K Buy
72
+28
+64% +$1.84K ﹤0.01% 4955
2024
Q1 		$3.35K Buy
44
+24
+120% +$2.28K ﹤0.01% 4880
2023
Q4 		$2.28K Sell
20
-9
-31% -$769 ﹤0.01% 5244
2023
Q3 		$3.17K Buy
+29
New +$4.37K ﹤0.01% 5046
2023
Q2 		– Sell
-1
Closed – – 6417
2023
Q1 		$0 Hold
1
– – ﹤0.01% 6378
2022
Q4 		$0 Buy
+1
New +$295 ﹤0.01% 6477

Other funds holding XAGE

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Tower Research Capital (TRC)'s XAGE Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 1,631 shares — an estimated $4.11K sold.

Tower Research Capital (TRC) first reported a position in XAGE in Q4 2022 and held it in 8 quarters. The position peaked at $4.11K in Q2 2025. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,631 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $4.11K.
  • Tower Research Capital (TRC) first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2022 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Longevity Health Holdings, Inc. Common Stock position peaked at $4.11K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.